Suppression of Metastasis of Colon Cancer to Liver in Mouse Models by Pretreatment with Extracellular Vesicles Derived from Nanog-Overexpressing Colon-26 Cancer Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312794 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Takuya Henmi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei 184-8588, Tokyo, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Colonic Neoplasms, Nanog Homeobox Protein, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, TUAT and JSPS KAKENHI.
Abstract (Originalsprache)
It has been demonstrated that cancer cells that have survived cancer treatment may be more malignant than the original cancer cells. These cells are considered the main cause of metastasis in prognosis. A Nanog-overexpressing colon-26 (Nanog+colon26) was generated to obtain such a malignant cancer cell model, which was confirmed by enhancement of metastatic potential by in vivo tests using mice. Extracellular vesicles (EVs) secreted from Nanog+colon26 cells (Nanog+colon26EVs) were administered to mice three times per week for three weeks. Subsequently, Nanog+colon26 cells were administered, and metastatic colonies were analyzed two weeks later. The results demonstrated that the administration of EVs suppressed metastasis. Nanog+colon26EVs enhanced phagocytic activity and M1 marker CD80 of a macrophage cell line J774.1. These suggested the enforcement of tumor-suppressive properties of macrophages and their contribution to the in vivo suppression of metastasis. Small RNA sequencing was conducted to identify Nanog-dependent miRNAs that exhibited significant changes (Fc ≥ 1.5 or Fc ≤ 1/1.5; p < 0.05) in Nanog+colon26EVs relative to colon26EVs. Nine miRNAs (up-regulated: four, down-regulated: five) were identified, and 623 genes were predicted to be their target genes. Of the 623 genes identified, nine genes were predicted to be highly relevant to macrophage functions such as phagocytosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei 184-8588, Tokyo, Japan.
- Bioresource Laboratories, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei 184-8588, Tokyo, Japan.
ORCID-Profile: Mikako Saito
Förderung
- Japan Society for the Promotion of Science
- TUAT and JSPS KAKENHI
Zitieren
APA
Henmi, T., Matsuoka, H., Katayama, N., & Saito, M. (2024). Suppression of Metastasis of Colon Cancer to Liver in Mouse Models by Pretreatment with Extracellular Vesicles Derived from Nanog-Overexpressing Colon-26 Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312794
Vancouver
Henmi T, Matsuoka H, Katayama N, Saito M. Suppression of Metastasis of Colon Cancer to Liver in Mouse Models by Pretreatment with Extracellular Vesicles Derived from Nanog-Overexpressing Colon-26 Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312794
BibTeX
@article{Henmi2024,
author = {Henmi, Takuya and Matsuoka, Hideaki and Katayama, Noa and Saito, Mikako},
title = {Suppression of Metastasis of Colon Cancer to Liver in Mouse Models by Pretreatment with Extracellular Vesicles Derived from Nanog-Overexpressing Colon-26 Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312794}
}
EUVIMED